Drug Shortage Report for OPTIRAY 320 (ULTRAJECT)
| Report ID | 241513 |
| Drug Identification Number | 02035626 |
| Brand name | OPTIRAY 320 (ULTRAJECT) |
| Common or Proper name | loversol injection |
| Company Name | LIEBEL-FLARSHEIM COMPANY LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | IOVERSOL |
| Strength(s) | 68% |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVASCULAR INTRAVASCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30 mL, 50 mL, 75 mL, 100 mL, 125 mL |
| ATC code | V08AB |
| ATC description | X-RAY CONTRAST MEDIA, IODINATED |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-10-29 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-04-30 |
| Company comments | This pre-filled syringe version is not marketed. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 8800 DURANT RD. RALEIGH, NORTH CAROLINA UNITED STATES 27616 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-04-30 | French | Compare |
| v6 | 2025-04-30 | English | Compare |
| v5 | 2024-10-30 | English | Compare |
| v4 | 2024-10-29 | French | Compare |
| v3 | 2024-10-29 | English | Compare |
| v2 | 2024-10-29 | French | Compare |
| v1 | 2024-10-29 | English | Compare |
Showing 1 to 7 of 7